90702-07-1 Usage
Function
Dopamine agonist and antiparkinsonian agent
Mechanism of Action
Stimulates dopamine receptors, improving motor symptoms in Parkinson's disease patients
Other Uses
Treatment of restless legs syndrome and vertigo
Administration
Typically administered orally in tablet form
Efficacy
Shown to improve symptoms and quality of life in Parkinson's disease patients
Caution
Should be used under the guidance of a healthcare professional
Monitoring
Healthcare supervision necessary to monitor for potential side effects and drug interactions
Check Digit Verification of cas no
The CAS Registry Mumber 90702-07-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,0,7,0 and 2 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 90702-07:
(7*9)+(6*0)+(5*7)+(4*0)+(3*2)+(2*0)+(1*7)=111
111 % 10 = 1
So 90702-07-1 is a valid CAS Registry Number.
90702-07-1Relevant academic research and scientific papers
Succinimidation by N-Bromosuccinimide of N,N-Dimethylamido and N,N-Dimethylamino Groups
Caristi, Corrado,Ferlazzo, Alida,Gattuso, Mario
, p. 281 - 285 (2007/10/02)
N,N-Dimethylamides (1)-(6) and N,N-dimethylamines (7)-(10) are converted by the action of N-bromosuccinimide (NBS) in carbon tetrachloride and in the presence of a catalytic amount of benzoyl peroxide into the corresponding succinimido derivatives (11)-(2
